Pharming Group N.V.
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| FY2020 | 276.27x | $0.06 | $15.20 |
| FY2021 | 388.70x | $0.02 | $8.94 |
| FY2022 | 580.53x | $0.02 | $11.03 |
| FY2025 | 4,202.50x | $0.00 | $16.81 |
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| FY2020 | 276.27x | $0.06 | $15.20 |
| FY2021 | 388.70x | $0.02 | $8.94 |
| FY2022 | 580.53x | $0.02 | $11.03 |
| FY2025 | 4,202.50x | $0.00 | $16.81 |